Letter to the EditorConclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions
References (11)
- et al.
Assessing the introduction of universal rotavirus vaccination in the Netherlands
Vaccine
(2008) - et al.
The cost-utility of rotavirus vaccination with RotavirusTM (RIX4414) in the Netherlands
Vaccine
(2008) - et al.
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
Lancet
(2007) - et al.
Efficay and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study
Lancet
(2008) - et al.
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis
New Engl J Med
(2006)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2009 Elsevier Ltd. All rights reserved.